Merck KGaA, Darmstadt, Germany announced that its proposed transaction with Intermolecular, Inc. was approved by the stockholders of Intermolecular at a special meeting held on July 17, 2019.     On May 6, 2019, Merck KGaA signed a definitive agreement to acquire Intermolecular through a subsidiary for $1.20 per share in an all-cash transaction, representing an equity value of approximately $62 million.   “Uniting our existing strength in the materials business with Intermolecular’s uniq...